Last updated: 3/17/2020
If you have a study that has been reviewed by an external IRB (e.g., WIRB or Advarra, another academic institution), we advise the following:
- Study teams should follow the UW’s COVID-19 guidance unless provided with more stringent guidance from the reviewing IRB.
- Study teams should consult with the lead study team, sponsor, and/or the reviewing IRB to determine whether anything needs to be reported about changes to study activities at UW-Madison to the reviewing IRB.
- Study teams do NOT need to submit any COVID-19-related changes to cede applications in ARROW unless required to do so by the reviewing IRB.
- Guidance for studies reviewed by the NCI CIRB can be found here.
If you have questions about the above, please contact the Reliance and Navigation Team (RELIANT; firstname.lastname@example.org) for assistance.